BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu P, Liang J, Yu F, Zhou Z, Tang J, Li K. miR-145 promotes osteosarcoma growth by reducing expression of the transcription factor friend leukemia virus integration 1. Oncotarget 2016;7:42241-51. [PMID: 27304058 DOI: 10.18632/oncotarget.9948] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang C, Jing J, Cheng L. Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma. Invest New Drugs 2018;36:1116-32. [DOI: 10.1007/s10637-018-0624-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
2 Pereira-Silva M, Alvarez-Lorenzo C, Concheiro A, Santos AC, Veiga F, Figueiras A. Nanomedicine in osteosarcoma therapy: Micelleplexes for delivery of nucleic acids and drugs toward osteosarcoma-targeted therapies. Eur J Pharm Biopharm 2020;148:88-106. [PMID: 31958514 DOI: 10.1016/j.ejpb.2019.10.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
3 Liu T, Xia L, Yao Y, Yan C, Fan Y, Gajendran B, Yang J, Li YJ, Chen J, Filmus J, Spaner DE, Zacksenhaus E, Hao X, Ben-David Y. Identification of diterpenoid compounds that interfere with Fli-1 DNA binding to suppress leukemogenesis. Cell Death Dis 2019;10:117. [PMID: 30741932 DOI: 10.1038/s41419-019-1363-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
4 Delsin LEA, Roberto GM, Fedatto PF, Engel EE, Scrideli CA, Tone LG, Brassesco MS. Downregulated Adhesion-Associated microRNAs as Prognostic Predictors in Childhood Osteosarcoma. Pathol Oncol Res 2019;25:11-20. [DOI: 10.1007/s12253-017-0316-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
5 Wang C, Song J, Liu W, Yao Y, Kapranov P, Sample KM, Gajendran B, Zacksenhaus E, Hao X, Ben-David Y. FLI1 promotes protein translation via the transcriptional regulation of MKNK1 expression. Int J Oncol 2020;56:430-8. [PMID: 31894299 DOI: 10.3892/ijo.2019.4943] [Reference Citation Analysis]
6 Sawant D, Lilly B. MicroRNA-145 targets in cancer and the cardiovascular system: evidence for common signaling pathways. Vasc Biol 2020;2:R115-28. [PMID: 33283158 DOI: 10.1530/VB-20-0012] [Reference Citation Analysis]
7 Viera GM, Salomao KB, de Sousa GR, Baroni M, Delsin LEA, Pezuk JA, Brassesco MS. miRNA signatures in childhood sarcomas and their clinical implications. Clin Transl Oncol 2019;21:1583-623. [PMID: 30949930 DOI: 10.1007/s12094-019-02104-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
8 Yuan G, Zhao Y, Wu D, Gao Ch. Mir-150 Up-Regulates Glut1 and Increases Glycolysis in Osteosarcoma Cells. Asian Pac J Cancer Prev 2017;18:1127-31. [PMID: 28547952 DOI: 10.22034/APJCP.2017.18.4.1127] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
9 Wu G, Yu W, Zhang M, Yin R, Wu Y, Liu Q. MicroRNA-145-3p suppresses proliferation and promotes apotosis and autophagy of osteosarcoma cell by targeting HDAC4. Artif Cells Nanomed Biotechnol 2018;46:579-86. [PMID: 29893594 DOI: 10.1080/21691401.2018.1464459] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
10 Yang Y, Fang S. Small non-coding RNAs-based bone regulation and targeting therapeutic strategies. Mol Cell Endocrinol 2017;456:16-35. [PMID: 27888003 DOI: 10.1016/j.mce.2016.11.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
11 Ru N, Zhang F, Liang J, Du Y, Wu W, Wang F, Liu X. MiR-564 is down-regulated in osteosarcoma and inhibits the proliferation of osteosarcoma cells via targeting Akt. Gene 2018;645:163-9. [PMID: 29248580 DOI: 10.1016/j.gene.2017.12.028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
12 Poli V, Seclì L, Avalle L. The Microrna-143/145 Cluster in Tumors: A Matter of Where and When. Cancers (Basel) 2020;12:E708. [PMID: 32192092 DOI: 10.3390/cancers12030708] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
13 Zhou Y, Feng D, Gu X, Gao A, Liu Y. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145. Anticancer Drugs 2021;32:168-77. [PMID: 32826416 DOI: 10.1097/CAD.0000000000000984] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Chen Z, Xu W, Zhang D, Chu J, Shen S, Ma Y, Wang Q, Liu G, Yao T, Huang Y, Ye H, Wang J, Ma J, Fan S. circCAMSAP1 promotes osteosarcoma progression and metastasis by sponging miR-145-5p and regulating FLI1 expression. Mol Ther Nucleic Acids 2021;23:1120-35. [PMID: 33664993 DOI: 10.1016/j.omtn.2020.12.013] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Avalle L, Incarnato D, Savino A, Gai M, Marino F, Pensa S, Barbieri I, Stadler MB, Provero P, Oliviero S, Poli V. MicroRNAs-143 and -145 induce epithelial to mesenchymal transition and modulate the expression of junction proteins. Cell Death Differ 2017;24:1750-60. [PMID: 28644441 DOI: 10.1038/cdd.2017.103] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]